UK markets closed

Anebulo Pharmaceuticals, Inc. (ANEB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0400+0.0900 (+3.05%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
Total revenue
0
0
0
0
Operating expenses
Research development
4,839
5,600
2,962
2,270
Selling general and administrative
5,823
6,183
3,870
1,344
Total operating expenses
10,663
11,784
6,831
3,614
Operating income or loss
-10,663
-11,784
-6,831
-3,614
Interest expense
-
-
0
11.767
Total other income/expenses net
-7.216
-41.146
-1.777
-26,628
Income before tax
-10,492
-11,732
-6,826
-30,253
Income from continuing operations
-10,492
-11,732
-6,826
-30,253
Net income
-10,492
-11,732
-6,826
-30,253
Net income available to common shareholders
-10,492
-11,732
-6,826
-38,461
Basic EPS
-0.46
-0.47
-0.29
-2.83
Diluted EPS
-0.46
-0.47
-0.29
-2.83
Basic average shares
25,629
25,074
23,345
13,613
Diluted average shares
25,629
25,074
23,345
13,613